Cell & Tissue Therapies WA (CTTWA)

Site

RPH Cell & Tissue Therapies WA (CTTWA)

Accreditation No.

19786

Site No.

23076

Date of Accreditation

22 Oct 2015

Address

Level 2 North Block, Wellington Street
Perth, WA 6000
Australia

rph.health.wa.gov.au

Contact

Dr Zlatibor Velickovic P: +61 (08) 92241987

Availability

Services not available to external clients

Supervision

HPS (Haemopoietic processing, storage)

Scope of Accreditation

RPH Cell & Tissue Therapies WA (CTTWA)

ISO 15189 (2022)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Haematology - Full blood examination Blood Leucocyte count (white blood cell count, WBCC)
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) Blood; Bone marrow CD16; CD19; CD3; CD34; CD4; CD45; CD56; CD8; Total leucocyte number; Total lymphocyte number; Viable cell count
Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProducts received from AN 19801 SN 23095 and AN 19786 SN 23076 Bone marrow; Cord blood; Haemopoietic progenitor cells Processing; Storage (includes freezing/thawing)

The only data displayed is that deemed relevant and necessary for the clear description of the Activities and Services covered by the Scope of Accreditation (SoA).

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.

The Product column may also describe an Item or Material.

The Limitations column may also describe the Range.